EGFR Mutated Non-small Cell Lung Cancer Patients trials recruiting in Massachusetts

Fewer than 3 recruiting trials found.

All EGFR Mutated Non-small Cell Lung Cancer Patients trials nationally

Cities in Massachusetts

Recruiting trials in Massachusetts

• Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
  NCT07315113 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston